Literature DB >> 32400971

MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.

Samantha L Strickland1, Joseph S Reddy2, Mariet Allen1, Aurelie N'songo1, Jeremy D Burgess1, Morgane M Corda1, Travis Ballard1, Xue Wang2, Minerva M Carrasquillo1, Joanna M Biernacka3, Gregory D Jenkins3, Shubhabrata Mukherjee4, Kevin Boehme5, Paul Crane4, John S Kauwe5, Nilüfer Ertekin-Taner1,6.   

Abstract

INTRODUCTION: MAPT H1 haplotype is implicated as a risk factor for neurodegenerative diseases including Alzheimer's disease (AD).
METHODS: Using Alzheimer's Disease Genetics Consortium (ADGC) genome-wide association study (GWAS) data (n = 18,841), we conducted a MAPT H1/H2 haplotype-stratified association to discover MAPT haplotype-specific AD risk loci.
RESULTS: We identified 11 loci-5 in H2-non-carriers and 6 in H2-carriers-although none of the MAPT haplotype-specific associations achieved genome-wide significance. The most significant H2 non-carrier-specific association was with a NECTIN2 intronic (P = 1.33E-07) variant, and that for H2 carriers was near NKX6-1 (P = 1.99E-06). The GABRG2 locus had the strongest epistasis with MAPT H1/H2 variant rs8070723 (P = 3.91E-06). Eight of the 12 genes at these loci had transcriptome-wide significant differential expression in AD versus control temporal cortex (q < 0.05). Six genes were members of the brain transcriptional co-expression network implicated in "synaptic transmission" (P = 9.85E-59), which is also enriched for neuronal genes (P = 1.0E-164), including MAPT. DISCUSSION: This stratified GWAS identified loci that may confer AD risk in a MAPT haplotype-specific manner. This approach may preferentially enrich for neuronal genes implicated in synaptic transmission.
© 2020 The Authors. Alzheimer's & Dementia published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

Entities:  

Keywords:  zzm321990MAPTzzm321990; Alzheimer's disease; case-control studies; co-expression networks; differential gene expression; haplotype-stratified genome-wide association

Mesh:

Substances:

Year:  2020        PMID: 32400971      PMCID: PMC7983911          DOI: 10.1002/alz.12099

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  65 in total

1.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.

Authors:  Günter U Höglinger; Nadine M Melhem; Dennis W Dickson; Patrick M A Sleiman; Li-San Wang; Lambertus Klei; Rosa Rademakers; Rohan de Silva; Irene Litvan; David E Riley; John C van Swieten; Peter Heutink; Zbigniew K Wszolek; Ryan J Uitti; Jana Vandrovcova; Howard I Hurtig; Rachel G Gross; Walter Maetzler; Stefano Goldwurm; Eduardo Tolosa; Barbara Borroni; Pau Pastor; Laura B Cantwell; Mi Ryung Han; Allissa Dillman; Marcel P van der Brug; J Raphael Gibbs; Mark R Cookson; Dena G Hernandez; Andrew B Singleton; Matthew J Farrer; Chang-En Yu; Lawrence I Golbe; Tamas Revesz; John Hardy; Andrew J Lees; Bernie Devlin; Hakon Hakonarson; Ulrich Müller; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-06-19       Impact factor: 38.330

Review 2.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

3.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

Authors:  I D'Souza; P Poorkaj; M Hong; D Nochlin; V M Lee; T D Bird; G D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

4.  Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.

Authors:  Kunie Ando; Karen Tomimura; Véronique Sazdovitch; Valérie Suain; Zehra Yilmaz; Michèle Authelet; Marième Ndjim; Cristina Vergara; Mounir Belkouch; Marie-Claude Potier; Charles Duyckaerts; Jean-Pierre Brion
Journal:  Neurobiol Dis       Date:  2016-05-31       Impact factor: 5.996

5.  Changes in methylation within the STK32B promoter are associated with an increased risk for generalized anxiety disorder in adolescents.

Authors:  Diana M Ciuculete; Adrian E Boström; Anna-Kaisa Tuunainen; Farah Sohrabi; Lara Kular; Maja Jagodic; Sarah Voisin; Jessica Mwinyi; Helgi B Schiöth
Journal:  J Psychiatr Res       Date:  2018-03-26       Impact factor: 4.791

Review 6.  The GABAergic system as a therapeutic target for Alzheimer's disease.

Authors:  Beatriz Calvo-Flores Guzmán; Chitra Vinnakota; Karan Govindpani; Henry J Waldvogel; Richard L M Faull; Andrea Kwakowsky
Journal:  J Neurochem       Date:  2018-08-01       Impact factor: 5.372

7.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

8.  Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.

Authors:  Pau Pastor; Mario Ezquerra; J Christian Perez; Sumi Chakraverty; Joanne Norton; Brad A Racette; Dan McKeel; Joel S Perlmutter; Eduardo Tolosa; Alison M Goate
Journal:  Ann Neurol       Date:  2004-08       Impact factor: 10.422

9.  Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.

Authors:  Fanggeng Zou; High Seng Chai; Curtis S Younkin; Mariet Allen; Julia Crook; V Shane Pankratz; Minerva M Carrasquillo; Christopher N Rowley; Asha A Nair; Sumit Middha; Sooraj Maharjan; Thuy Nguyen; Li Ma; Kimberly G Malphrus; Ryan Palusak; Sarah Lincoln; Gina Bisceglio; Constantin Georgescu; Naomi Kouri; Christopher P Kolbert; Jin Jen; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Ronald C Petersen; Neill R Graff-Radford; Dennis W Dickson; Steven G Younkin; Nilüfer Ertekin-Taner
Journal:  PLoS Genet       Date:  2012-06-07       Impact factor: 5.917

10.  A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.

Authors:  Sekar Kathiresan; Alisa K Manning; Serkalem Demissie; Ralph B D'Agostino; Aarti Surti; Candace Guiducci; Lauren Gianniny; Nöel P Burtt; Olle Melander; Marju Orho-Melander; Donna K Arnett; Gina M Peloso; Jose M Ordovas; L Adrienne Cupples
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

View more
  9 in total

1.  Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer's disease risk in humans.

Authors:  Yiyi Ma; Lei Yu; Marta Olah; Rebecca Smith; Stephanie R Oatman; Mariet Allen; Ehsan Pishva; Bin Zhang; Vilas Menon; Nilüfer Ertekin-Taner; Katie Lunnon; David A Bennett; Hans-Ulrich Klein; Philip L De Jager
Journal:  Alzheimers Dement       Date:  2021-09-05       Impact factor: 16.655

2.  EPIGENOMIC FEATURES RELATED TO MICROGLIA ARE ASSOCIATED WITH ATTENUATED EFFECT OF APOE ε4 ON ALZHEIMER'S DISEASE RISK IN HUMANS.

Authors:  Yiyi Ma; Lei Yu; Marta Olah; Rebecca Smith; Stephanie R Oatman; Mariet Allen; Ehsan Pishva; Bin Zhang; Vilas Menon; Nilüfer Ertekin-Taner; Katie Lunnon; David A Bennett; Hans-Ulrich Klein; Philip L De Jager
Journal:  Alzheimers Dement       Date:  2020-12-07       Impact factor: 16.655

3.  Genome-wide association study and functional validation implicates JADE1 in tauopathy.

Authors:  Kurt Farrell; SoongHo Kim; Natalia Han; Megan A Iida; Elias M Gonzalez; Marcos Otero-Garcia; Jamie M Walker; Timothy E Richardson; Alan E Renton; Shea J Andrews; Brian Fulton-Howard; Jack Humphrey; Ricardo A Vialle; Kathryn R Bowles; Katia de Paiva Lopes; Kristen Whitney; Diana K Dangoor; Hadley Walsh; Edoardo Marcora; Marco M Hefti; Alicia Casella; Cheick T Sissoko; Manav Kapoor; Gloriia Novikova; Evan Udine; Garrett Wong; Weijing Tang; Tushar Bhangale; Julie Hunkapiller; Gai Ayalon; Robert R Graham; Jonathan D Cherry; Etty P Cortes; Valeriy Y Borukov; Ann C McKee; Thor D Stein; Jean-Paul Vonsattel; Andy F Teich; Marla Gearing; Jonathan Glass; Juan C Troncoso; Matthew P Frosch; Bradley T Hyman; Dennis W Dickson; Melissa E Murray; Johannes Attems; Margaret E Flanagan; Qinwen Mao; M-Marsel Mesulam; Sandra Weintraub; Randy L Woltjer; Thao Pham; Julia Kofler; Julie A Schneider; Lei Yu; Dushyant P Purohit; Vahram Haroutunian; Patrick R Hof; Sam Gandy; Mary Sano; Thomas G Beach; Wayne Poon; Claudia H Kawas; María M Corrada; Robert A Rissman; Jeff Metcalf; Sara Shuldberg; Bahar Salehi; Peter T Nelson; John Q Trojanowski; Edward B Lee; David A Wolk; Corey T McMillan; C Dirk Keene; Caitlin S Latimer; Thomas J Montine; Gabor G Kovacs; Mirjam I Lutz; Peter Fischer; Richard J Perrin; Nigel J Cairns; Erin E Franklin; Herbert T Cohen; Towfique Raj; Inma Cobos; Bess Frost; Alison Goate; Charles L White Iii; John F Crary
Journal:  Acta Neuropathol       Date:  2021-11-01       Impact factor: 15.887

4.  Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease.

Authors:  Joseph S Reddy; Mariet Allen; Charlotte C G Ho; Stephanie R Oatman; Özkan İş; Zachary S Quicksall; Xue Wang; Jiangli Jin; Tulsi A Patel; Troy P Carnwath; Thuy T Nguyen; Kimberly G Malphrus; Sarah J Lincoln; Minerva M Carrasquillo; Julia E Crook; Takahisa Kanekiyo; Melissa E Murray; Guojun Bu; Dennis W Dickson; Nilüfer Ertekin-Taner
Journal:  Acta Neuropathol Commun       Date:  2021-05-21       Impact factor: 7.578

5.  Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions.

Authors:  Xue Wang; Mariet Allen; Özkan İş; Joseph S Reddy; Frederick Q Tutor-New; Monica Castanedes Casey; Minerva M Carrasquillo; Stephanie R Oatman; Yuhao Min; Yan W Asmann; Cory Funk; Thuy Nguyen; Charlotte Cg Ho; Kimberly G Malphrus; Nicholas T Seyfried; Allan I Levey; Steven G Younkin; Melissa E Murray; Dennis W Dickson; Nathan D Price; Todd E Golde; Nilüfer Ertekin-Taner
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 19.456

Review 6.  Tauopathies: new perspectives and challenges.

Authors:  Yi Zhang; Kai-Min Wu; Liu Yang; Qiang Dong; Jin-Tai Yu
Journal:  Mol Neurodegener       Date:  2022-04-07       Impact factor: 14.195

7.  In Alzheimer-prone brain regions, metabolism and risk-gene expression are strongly correlated.

Authors:  Fengdan Ye; Quentin Funk; Elijah Rockers; Joshua M Shulman; Joseph C Masdeu; Belen Pascual
Journal:  Brain Commun       Date:  2022-08-25

8.  Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.

Authors:  Ping Guo; Weiming Gong; Yuanming Li; Lu Liu; Ran Yan; Yanjun Wang; Yanan Zhang; Zhongshang Yuan
Journal:  BMC Med       Date:  2022-06-22       Impact factor: 11.150

9.  MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.

Authors:  Samantha L Strickland; Joseph S Reddy; Mariet Allen; Aurelie N'songo; Jeremy D Burgess; Morgane M Corda; Travis Ballard; Xue Wang; Minerva M Carrasquillo; Joanna M Biernacka; Gregory D Jenkins; Shubhabrata Mukherjee; Kevin Boehme; Paul Crane; John S Kauwe; Nilüfer Ertekin-Taner
Journal:  Alzheimers Dement       Date:  2020-05-13       Impact factor: 16.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.